VentiRx Pharmaceuticals logo

VentiRx Pharmaceuticals

Advancing healthcare innovations with targeted therapies for cancer, respiratory, and autoimmune diseases.

est. 2006

VS
Zealand Pharma logo

Zealand Pharma

Changing lives with next generation peptide therapeutics

390 employees · est. 1998 · Denmark

Zealand Pharma is the older company (2006 vs 1998).

Side-by-Side Comparison

VentiRx Pharmaceuticals Zealand Pharma
Founded
2006 1998 older
Headquarters
Not tracked yet Denmark
Employees
Not tracked yet 390
Industry
Biotechnology, Health Care, Health and Wellness Biopharma, Biotechnology, Health Care
Funding Stage
Series B Post Ipo Equity
Total Funding
$104.50M $8.93B
Funding Rounds
4 7
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceutical, Clinical-stage, Cancer Treatment, Respiratory Diseases, Autoimmune Diseases, Small Molecule Therapies, TLR8 Agonists, TLR8 Antagonists, Vaccine Adjuvants, Oncology, Allergy Treatment, Immune Response Stimulation, Celgene Corporation Collaboration, Seattle Headquarters, San Diego Operations Pharmaceuticals, Peptide Therapeutics, Clinical Development, Type 2 Diabetes Treatment, Drug Discovery, Gastrointestinal Diseases, Metabolic Diseases, Clinical License Collaboration, Pre-clinical License Collaboration, GLP-1 Analogue, Ischemic Reperfusion Injuries, Short Bowel Syndrome, Hypoglycemia Treatment, Danish Biotech Company
Website
ventirx.com zealandpharma.com
VentiRx Pharmaceuticals logo

About VentiRx Pharmaceuticals

VentiRx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing targeted therapies for cancer, respiratory, and autoimmune diseases. The company's product pipeline includes VTX-2337, a small molecule TLR8 agonist designed to stimulate myeloid dendritic cells and monocytes...

Zealand Pharma logo

About Zealand Pharma

Zealand Pharma Slogan: Changing lives with next generation peptide therapeutics Description: Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) is a Danish biotechnology company founded in 1998, with a mission to change lives through next generation peptide medicines. The company has a strong focus on spe...

We will tell you when either one moves

BounceWatch watches VentiRx Pharmaceuticals and Zealand Pharma for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at VentiRx Pharmaceutical... and Zealand Pharma — by email.

Frequently Asked Questions

VentiRx Pharmaceuticals — Advancing healthcare innovations with targeted therapies for cancer, respiratory, and autoimmune diseases.. Zealand Pharma — Changing lives with next generation peptide therapeutics. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
VentiRx Pharmaceuticals has raised $104.50M while Zealand Pharma has raised $8.93B.
VentiRx Pharmaceuticals and Zealand Pharma operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare VentiRx Pharmaceuticals with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at VentiRx Pharmaceuticals on 12 Sep 2024, and Zealand Pharma on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes